Recently, a few researchers have made progress on anti-diabetic therapies using MSNs; however, their approaches are limited to insulin delivery to treat insulin based diabetes by controlled delivery or utilizing MSNs as sensors. The gene discussed is INS; the disease is diabetes mellitus.